Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2025-12-24 @ 1:20 PM
Study NCT ID:
NCT05743595
Status:
RECRUITING
Last Update Posted:
2025-12-10
First Post:
2023-02-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-14
First Submit QC Date:
None
Study First Post Date:
2023-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-10
Last Update Post Date Type:
ESTIMATED